Centrosome amplification and prognosis in breast cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
A new published study has shown that Altamira Therapeutics' SemaPhore technology used with superoxide dismutase 2 (SOD2) mRNA has successfully treated abdominal aortic aneurysm (AAA) in a mouse model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results